Edition:
India

Proteon Therapeutics Inc (PRTO.OQ)

PRTO.OQ on NASDAQ Stock Exchange Global Market

2.35USD
19 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.35
Open
$2.35
Day's High
$2.35
Day's Low
$2.35
Volume
284
Avg. Vol
9,434
52-wk High
$2.85
52-wk Low
$1.15

Chart for

About

Proteon Therapeutics, Inc. is a late-stage biopharmaceutical company, which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease. The Company is involved in research and development activities. The Company's product candidate, product candidate, vonapanitase, formerly... (more)

Overall

Beta: --
Market Cap(Mil.): $46.69
Shares Outstanding(Mil.): 17.62
Dividend: --
Yield (%): --

Financials

BRIEF-Proteon Says Has Sufficient Capital For Operations Into Q4 Of 2019

* PROTEON THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

14 Mar 2018

BRIEF-Proteon Therapeutics Completes Enrollment In Patency-2, Phase 3 Clinical Trial Of Investigational Vonapanitase

* PROTEON THERAPEUTICS COMPLETES ENROLLMENT IN PATENCY-2, PHASE 3 CLINICAL TRIAL OF INVESTIGATIONAL VONAPANITASE Source text for Eikon: Further company coverage:

06 Mar 2018

BRIEF-Proteon Therapeutics Q3 ‍loss per share $1.08​

* Proteon Therapeutics announces third quarter 2017 financial results

07 Nov 2017

Earnings vs. Estimates